IL6 and cardiomyopathy: As a result, CAR-T cell-associated cardiotoxicity was usually accompanied by a marked rise in IL-6 (54), which contributed to complement and coagulation cascade activation and led to vascular leakage, coagulopathy, and cardiomyopathy (55).